Detalles de la búsqueda
1.
Drug- and Toxin-Induced Opsoclonus - a Systematized Review, including a Case Report on Amantadine-Induced Opsoclonus in Multiple System Atrophy.
Tremor Other Hyperkinet Mov (N Y);
14: 23, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38737300
2.
Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services.
BMJ Open;
14(4): e083550, 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38663923
3.
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV.
Clin Pharmacol Ther;
115(6): 1450-1459, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38519844
4.
Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures.
Open Forum Infect Dis;
11(2): ofae023, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38379570
5.
[Pharmacovigilance. Withdrawal and rebound effects: not just with psychotropic drugs]. / Pharmacovigilance. Sevrage et effet rebond: pas seulement avec les psychotropes.
Rev Med Suisse;
20(856-7): 96-101, 2024 Jan 17.
Artículo
en Francés
| MEDLINE | ID: mdl-38231110
6.
Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland.
Lancet Reg Health Eur;
36: 100793, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38162253
7.
Population pharmacokinetic analysis of doravirine in real-world people with HIV.
Br J Clin Pharmacol;
90(4): 1058-1065, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37994177
8.
Improving Data Collection in Pregnancy Safety Studies: Towards Standardisation of Data Elements in Pregnancy Reports from Public and Private Partners, A Contribution from the ConcePTION Project.
Drug Saf;
47(3): 227-236, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38114757
9.
Development and validation of a multiplex HPLC-MS/MS assay for the monitoring of JAK inhibitors in patient plasma.
J Chromatogr B Analyt Technol Biomed Life Sci;
1230: 123917, 2023 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37956468
10.
Antidepressants and the risk of bleeding in the era of anti-amyloid drugs.
Alzheimers Dement;
19(12): 5847-5848, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37587609
11.
Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment.
Front Pharmacol;
14: 1210002, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37261286
12.
Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN).
Front Pharmacol;
14: 1040584, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37180729
13.
Four cases of audio-vestibular disorders related to immunisation with SARS-CoV-2 mRNA vaccines.
Int J Audiol;
62(6): 587-591, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35510657
14.
Cardiovascular therapy use, modification, and in-hospital death in patients with COVID-19: A cohort study.
PLoS One;
17(11): e0277653, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36417470
15.
[Janus kinase inhibitors : new perspectives for precision medicine ?] / Inhibiteurs des Janus kinases : nouvelles perspectives pour la médecine de précision ?
Rev Med Suisse;
18(800): 1979-1983, 2022 Oct 19.
Artículo
en Francés
| MEDLINE | ID: mdl-36259705
16.
Pharmacogenomic-guided clozapine administration based on HLA-DQB1, HLA-B and SLCO1B3-SLCO1B7 variants: an effectiveness and cost-effectiveness analysis.
Front Pharmacol;
13: 1016669, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36313369
17.
Multifocal lymphadenopathies with polyclonal reactions primed after EBV infection in a mRNA-1273 vaccine recipient.
Swiss Med Wkly;
152: w30188, 2022 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35748061
18.
Scaling-up hepatitis C screening and treatment in Swiss outpatient psychiatric settings: A cost-effectiveness analysis.
JHEP Rep;
4(5): 100464, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35368992
19.
Evaluating the risk of drug-drug interactions with pharmacokinetic boosters: the case of ritonavir-enhanced nirmatrelvir to prevent severe COVID-19.
Clin Microbiol Infect;
28(8): 1044-1046, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35358684
20.
Symptoms and quality of life at 1-year follow up of patients discharged after an acute COVID-19 episode.
Swiss Med Wkly;
151: w30093, 2021 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34909433